OTCPK:ARLZQ - Post by User
Comment by
snootchybootchyon Mar 18, 2017 3:52pm
146 Views
Post# 25997975
RE:RE:RE:CEO Purchased Half Million Shares!
RE:RE:RE:CEO Purchased Half Million Shares!kuatolives/goldendilemma, you fellas make good points but I'm really looking at Aralez in a different way. My feeling is that the market has declared Yosprala a failure much too early. There had been only five months of sales data since the drug was approved, and that duration spanned the Christmas/New Years holiday to boot. Five months is much too early to start forecasting future Yosprala sales, especially when management has not had the opportunity yet to roll out their combination sales strategy with Zontivity.
At any rate, I would refer skeptics to the drug Entresto from Novartis. Launch for the heart failure drug was also very slow but uptake is really starting to pick up steam now, about 20 months after it was approved.
I think the bottom is in. Shorters can try to discount Aralez to its cash level but clearly there is going to be support at the same levels insiders made their large purchases.